-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Azotomycin is an important antibiotic compound that has been widely used in the treatment of various bacterial infections.
The compound is a polycyclic antibiotic that contains a unique lactone ring and a nitrogen-containing side chain.
The synthesis of azotomycin has been an active area of research in the chemical industry, with several different synthetic routes being developed over the years.
One of the earliest synthetic routes for azotomycin was developed by the German chemist Adolf Butenandt in the 1950s.
This route involved the synthesis of the nitrogen-containing side chain and the lactone ring separately, followed by their coupling through a series of chemical reactions.
The process was complex and time-consuming, and it was later replaced by more efficient synthetic routes.
One of the most popular synthetic routes for azotomycin involves the use of a modified version of the Butenandt route.
In this route, the nitrogen-containing side chain is synthesized using a series of chemical reactions, and the lactone ring is synthesized using a different set of reactions.
The two synthetic routes are then combined through a series of chemical reactions to form the final compound.
This route is widely used in the chemical industry due to its high yield and purity of the final product.
Another synthetic route for azotomycin involves the use of biotechnology.
In this route, a genetically modified microorganism is used to synthesize the compound.
The microorganism is engineered to express the genes necessary for the synthesis of the nitrogen-containing side chain and the lactone ring, and the two components are then combined to form the final compound.
This route is advantageous due to its low cost and high yield, as well as the fact that it does not require the use of toxic chemicals.
There are also several other synthetic routes for azotomycin that have been developed in recent years, including one that involves the use of a metal-catalyzed reaction.
This route involves the use of a metal catalyst to speed up the reaction between the nitrogen-containing side chain and the lactone ring, resulting in a more efficient and cost-effective
